Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly K Filipski

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Pharmacogenomics and Personalized Medicine|September 2, 2017
Updating the landscape of direct-to-consumer pharmacogenomic testingKelly K Filipski, John D Murphy, Kathy J Helzlsouer
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Interaction of Cisplatin with the human organic cation transporter 2Kelly K Filipski, Walter J Loos, Jaap Verweij, et al.
Frontiers in Genetics|May 1, 2014
Pharmacogenomics in oncology careKelly K Filipski, Leah E Mechanic, Rochelle Long, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 14, 2022
Overview of Research on Germline Genetic Variation in Immune Genes and Cancer OutcomesBrittany N Chao, Danielle M Carrick, Kelly K Filipski, et al.
Pharmacogenetics and Genomics|April 9, 2016
Dosing recommendations for pharmacogenetic interactions related to drug metabolismKelly K Filipski, Michael A Pacanowski, Anuradha Ramamoorthy, et al.
Plos Currents|June 7, 2014
Multi-marker Solid Tumor Panels Using Next-generation Sequencing to Direct Molecularly Targeted TherapiesMichael Marrone, Kelly K Filipski, Elizabeth M Gillanders, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 4, 2025
NCI-Funded Cancer Epidemiology Survivor Cohorts: Overview, Progress, and OpportunitiesLisa Gallicchio, Andrea N Burnett-Hartman, Kelly K Filipski, et al.
Journal of Palliative Medicine|November 10, 2023
Palliative Intent Treatment and Palliative Care Delivery for Individuals With Advanced Nonsmall Cell Lung Cancer and Melanoma: A Patterns of Care StudyMichelle A Mollica, Lisa Gallicchio, Jennifer L Stevens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 6, 2010
Influence of Oct1/Oct2-deficiency on cisplatin-induced changes in urinary N-acetyl-beta-D-glucosaminidaseRyan M Franke, Ashley M Kosloske, Cynthia S Lancaster, et al.
BMC Medical Informatics and Decision Making|June 1, 2017
Clinical decisions surrounding genomic and proteomic testing among United States veterans treated for lung cancer within the Veterans Health AdministrationOlga Efimova, Brygida Berse, Daniel W Denhalter, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Pharmacogenomics and Personalized Medicine|September 2, 2017
Updating the landscape of direct-to-consumer pharmacogenomic testingKelly K Filipski, John D Murphy, Kathy J Helzlsouer
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Interaction of Cisplatin with the human organic cation transporter 2Kelly K Filipski, Walter J Loos, Jaap Verweij, et al.
Frontiers in Genetics|May 1, 2014
Pharmacogenomics in oncology careKelly K Filipski, Leah E Mechanic, Rochelle Long, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 14, 2022
Overview of Research on Germline Genetic Variation in Immune Genes and Cancer OutcomesBrittany N Chao, Danielle M Carrick, Kelly K Filipski, et al.
Pharmacogenetics and Genomics|April 9, 2016
Dosing recommendations for pharmacogenetic interactions related to drug metabolismKelly K Filipski, Michael A Pacanowski, Anuradha Ramamoorthy, et al.
Plos Currents|June 7, 2014
Multi-marker Solid Tumor Panels Using Next-generation Sequencing to Direct Molecularly Targeted TherapiesMichael Marrone, Kelly K Filipski, Elizabeth M Gillanders, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 4, 2025
NCI-Funded Cancer Epidemiology Survivor Cohorts: Overview, Progress, and OpportunitiesLisa Gallicchio, Andrea N Burnett-Hartman, Kelly K Filipski, et al.
Journal of Palliative Medicine|November 10, 2023
Palliative Intent Treatment and Palliative Care Delivery for Individuals With Advanced Nonsmall Cell Lung Cancer and Melanoma: A Patterns of Care StudyMichelle A Mollica, Lisa Gallicchio, Jennifer L Stevens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 6, 2010
Influence of Oct1/Oct2-deficiency on cisplatin-induced changes in urinary N-acetyl-beta-D-glucosaminidaseRyan M Franke, Ashley M Kosloske, Cynthia S Lancaster, et al.
BMC Medical Informatics and Decision Making|June 1, 2017
Clinical decisions surrounding genomic and proteomic testing among United States veterans treated for lung cancer within the Veterans Health AdministrationOlga Efimova, Brygida Berse, Daniel W Denhalter, et al.
Pageof 3